Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9141 |
High Similarity |
NPD4908 |
Phase 1 |
0.904 |
High Similarity |
NPD1610 |
Phase 2 |
0.9 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8864 |
High Similarity |
NPD1613 |
Approved |
0.8864 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.872 |
High Similarity |
NPD1548 |
Phase 1 |
0.8702 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8626 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8626 |
High Similarity |
NPD2861 |
Phase 2 |
0.8496 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8496 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8462 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8296 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.803 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8029 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7986 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7972 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7943 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7933 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7931 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7917 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7907 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7902 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7881 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7872 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7852 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7847 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7823 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7769 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7762 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7762 |
Intermediate Similarity |
NPD6100 |
Approved |
0.773 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD290 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7681 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7671 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7632 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD968 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7582 |
Intermediate Similarity |
NPD37 |
Approved |
0.7581 |
Intermediate Similarity |
NPD940 |
Approved |
0.7581 |
Intermediate Similarity |
NPD846 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7548 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7548 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7548 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7547 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5494 |
Approved |
0.75 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7481 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7481 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7445 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7413 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7413 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.74 |
Intermediate Similarity |
NPD1511 |
Approved |
0.74 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7389 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7315 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7312 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7054 |
Approved |
0.728 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7266 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7256 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7255 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7248 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD3122 |
Phase 3 |
0.7214 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD228 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6353 |
Approved |
0.719 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7177 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7177 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7161 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD821 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7113 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7103
|
Intermediate Similarity |
NPD4062 |
Phase 3 |